Announcement Peptinovo Biopharma is a leading biotechnology company based in Ann Arbor revolutionizing the focused cancer therapies via its exclusive PALM™ nanotechnology has proudly declared its intellectual property an excellent milestone and a crucial manufacturing achievement in partnersh...
Announcement Cadrenal Therapeutics, Inc., a leading biopharmaceutical company establishing a tr5ansformative and excellent therapeutics to conquer over the limitations of the latest anticoagulation therapy has confirmed that their members of the management teak along with the CEO, Quang X. Pham, wi...
Announcement The CDC has agreed to adopt the delayed Hepatitis B Vaccine Dose on the suggestion of its advisory committee. The advisory recommended that integrating these vaccine shots will be beneficial as well as delayed because most of the patients are eligible to get dosed on reaching two month...
Announcement BMS will be signing in as the second most powerful partner to be added to the 2025 healthcare business list, following the Chinese biotech's fruitful business deal with AstraZeneca in March, worth $4.68 billion. In this race, the bidding is still making the headlines as Bristol Myers S...
Announcement Regulatory Bottlenecks Holding Back India’s Biotech Ambitions India has the talent and ambition to be a global biotech leader, but slow and complex regulations are holding it back. According to Dr. Raches Ella, Chief Development Officer at Bharat Biotech, the biggest hurdle is t...
Announcement Xoma Royalty, a company that has been quietly building a business by acquiring troubled biotech firms, has found its latest target. Late Monday, Xoma announced plans to acquire Generation Bio, a gene therapy developer whose market value has fallen below the cash it holds on its balance...
Announcement Takeda Strengthens Its Presence in Early-Stage Biotech Innovation Takeda Pharmaceutical has joined BaseLaunch, a venture creation and incubation platform focused on building early-stage biotech companies developing next-generation therapeutics. The move reinforces Takeda’s commi...
Announcement Sanofi Moves Quickly to Reinforce Its Future Pipeline After a tough week marked by a disappointing multiple sclerosis (MS) trial result, Sanofi has moved decisively to strengthen its long-term pipeline. The French drugmaker has signed two major licensing deals, worth up to $1.7 billio...
Announcement SK Capital Partners, LP, a well-known New York-based private investment entity focused on the life sciences, ingredients sectors and speciality materials, has declared that its syndicate has entered the deal to invest in Swixx BioPharma AG to elevate the Company’s future stage of...
Announcement Pharmanovia, a leading popular pharmaceutical company that markets the novel speciality drugs and the trusted developed medicines, has now introduced its Korjuny (Catumaxomab) in Germany. This new launch has made the T-cell connector trifunctional antibody drug the first ever and the o...
